Stockscreener 앱 받기
278.17
5.14%
13.60
시간 외 거래:
278.00
-0.17
-0.06%
Illumina Inc 주식(ILMN)의 최신 뉴스
Global Microfluidics Market by Product Type, Application, End User, and Region, 2026-2036 | $48.04 Billion Opportunity Driven by Point-of-Care Diagnostics and Automation - GlobeNewswire Inc.
RBC raises target for Illumina stock to USD 310 - AD HOC NEWS
Illumina (ILMN) Shares Skyrocket, What You Need To Know - Yahoo Finance
Illumina (ILMN) Shares Skyrocket, What You Need To Know - FinancialContent
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina stock gains 7.95 percent as RBC raises target - AD HOC NEWS
Illumina Inc Stock (ILMN) Moved Up by 7.85% on Oct 5: Drivers Behind the Movement - TradingKey
Illumina rises as recent analyst target hikes and index inclusion keep momentum intact - Quiver Quantitative
Illumina stock hits 52-week high at 280.44 USD By Investing.com - Investing.com South Africa
Illumina stock hits 52-week high at 280.44 USD - Investing.com
Illumina's Clinical Sequencing Revenue Seen as Durable Mid-Teens Grower, RBC Capital Markets Says - marketscreener.com
Illumina's Clinical Sequencing Revenue Seen as Durable Mid-Teens Grower, RBC Capital Markets Says - Yahoo Finance
RBC Capital raises Illumina stock price target on clinical sales - Investing.com
RBC Capital maintains Outperform rating on Illumina, $310 price target - TradingView
RBC raises target for Illumina stock to USD 310 - AD HOC NEWS
Illumina Inc : RBC Raises Target Price to $31 - Moomoo
Immunogenomics Market Size, Share, Trends, and Growth Forecast, 2026-2033 | NGS and Personalized Medicine Drive Market Toward USD 9.82 Billion at 5.97% CAGR - GlobeNewswire Inc.
Form 4 Illumina Inc For: 2 October By Investing.com - Investing.com South Africa
A director receives 107 shares instead of cash for quarterly retainer fees at Illumina (ILMN). - Stock Titan
A director receives stock for 100% of Q3 retainer fees at Illumina (ILMN) - Stock Titan
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina, Inc. (ILMN) Stock Forecasts - Yahoo Finance
Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Global Liver Cancer Diagnostics Market to Observe Impressive Growth at a CAGR of ~9% by 2034 | DelveInsight - GlobeNewswire Inc.
3 Reasons to Buy Grail (GRAL) Hand Over Fist in October - The Motley Fool
The Benchmark Matters: Evaluating TruPath Genome Beyond Individual Loci - Illumina
Where Will Illumina Stock Be in 5 Years If Its AI Bet Pays Off? - The Motley Fool
REGN or ILMN: Which Is the Better Value Stock Right Now? - Zacks Investment Research
Is the Options Market Predicting a Spike in Illumina Stock? - Yahoo Finance
Illumina Inc. stock underperforms Friday when compared to competitors - MarketWatch
Illumina stock adds 3.20 percent ahead of the open - AD HOC NEWS
Will Index Reshuffle Change Illumina (ILMN) Narrative - simplywall.st
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today - Benzinga
Illumina stock holds near its yearly high as targets diverge - AD HOC NEWS
Illumina stock heads into the open after a 2.27 percent drop - AD HOC NEWS
Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate - Zacks Investment Research
Illumina, Inc. (ILMN) Stock Analysis: Navigating a Complex Landscape with High Growth Potential - DirectorsTalk Interviews
Illumina, Inc.(NasdaqGS: ILMN) added to S&P 500 Equal Weighted - marketscreener.com
Illumina, Inc.(NasdaqGS: ILMN) added to S&P 500 Growth - marketscreener.com
Illumina, Inc.(NasdaqGS: ILMN) added to S&P 500 Health Care - marketscreener.com
Illumina, Inc.(NasdaqGS: ILMN) dropped from S&P 400 Health Care - marketscreener.com
Illumina Stock Drops 2.3% Before Monday’s S&P 500 Return; Volume Jumps Ninefold - TechStock²
Illumina Stock Is Up 133% This Year. Here’s Where It Could Go Further. - TIKR.com
Illumina Inc. stock underperforms Friday when compared to competitors - MarketWatch
Illumina Names Chief Commercial Officer and Chief Legal Officer - Medical Product Outsourcing
Illumina, Inc.(NasdaqGS: ILMN) dropped from Russell Small Cap Comp Value Index - marketscreener.com
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
1.08%
자본화:
|
볼륨(24시간):